1 down and 8 to go. The next 3 1/2 months should b
Post# of 72440
Posted On: 03/16/2016 7:45:06 AM
1 down and 8 to go. The next 3 1/2 months should be AWESOME.....
We are looking forward (See Forward-Looking Statements Below) to our fiscal year end of June 30, 2016 and we hope to announce/have announced:
Start of Kevetrin advanced study in ovarian cancer.
Start of Brilacidin ABSSSI Phase 3
Start of Brilacidin for Ulcerative Proctitis proof of concept trial (phase 2)
Top line data on Kevetrin Phase 1 trial for advanced solid tumors
Top line data on Prurisol Phase 2 trial for chronic plaque psoriasis
Interim analysis for Brilacidin Phase 2 trial for Oral Mucositis
Start of Retinoblastoma program, formulation and toxicity studies
Additional ototoxicity studies with Brilacidin in different concentrations
Gram- negative and anti-fungal progress
DONE...Submission of grant application for study of Kevetrin in Pancreatic cancer with renowned hospital.
We are looking forward (See Forward-Looking Statements Below) to our fiscal year end of June 30, 2016 and we hope to announce/have announced:
Start of Kevetrin advanced study in ovarian cancer.
Start of Brilacidin ABSSSI Phase 3
Start of Brilacidin for Ulcerative Proctitis proof of concept trial (phase 2)
Top line data on Kevetrin Phase 1 trial for advanced solid tumors
Top line data on Prurisol Phase 2 trial for chronic plaque psoriasis
Interim analysis for Brilacidin Phase 2 trial for Oral Mucositis
Start of Retinoblastoma program, formulation and toxicity studies
Additional ototoxicity studies with Brilacidin in different concentrations
Gram- negative and anti-fungal progress
DONE...Submission of grant application for study of Kevetrin in Pancreatic cancer with renowned hospital.
(5)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼